ViaLase has announced the treatment of the first patient in its U.S. Investigational Device Exemptio...

Samsung Bioepis has received a positive opinion from the European Medicines Agency’s Committee for M...

Lotus Pharmaceutical and LENZ Therapeutics have announced the submission of a New Drug Application (...

Kiora Pharmaceuticals has received a new U.S. patent (Patent No. 12,472,263) covering additional and...

Belite Bio has announced promising topline results from its global Phase 3 DRAGON trial, evaluating ...

Sandoz has officially launched Afqlir, its biosimilar referencing aflibercept, across European marke...

Ripple Therapeutics, a clinical-stage company developing polymer-free sustained release drug deliver...

Inflammasome Therapeutics has announced the completion of patient enrollment in its multicenter Phas...

Ocular Therapeutix has announced the randomization of the first patient in HELIOS-3, the second Phas...

A panel of leading ophthalmic surgeons shared their real-world experience with ArtIOLs® (Voptica S.L...